Table 1.
Participants’ demographics and clinical profiles.
| CRSwNP (n = 10) | Control (Without CRS) (n = 10) | ||
|---|---|---|---|
| Age (Mean ± SD) | 41.7 ± 7.9 | 35.7 ± 7.2 | |
| Gender | Male | 6 | 4 |
| Female | 4 | 6 | |
| Smoking Status * | Smoker | 2 | 1 |
| Non-smoker | 8 | 6 | |
| Previous smoker | 0 | 3 | |
| Previous Sinonasal Surgery | Yes | 8 | 0 |
| No | 2 | 10 | |
| Allergic Rhinitis | Yes | 10 | 2 |
| No | 0 | 8 | |
| Asthma | Yes | 5 | 1 |
| No | 5 | 9 | |
| SNOT-22 Score (Mean ± SD) | 38.2 ± 8.5 | 6.8 ± 9.6 | |
| Total Nasal Polyp Score ** (Mean ± SD) | 3.8 ± 1.6 | 0 | |
| Lund–Mackay Score (Mean ± SD) | 19 ± 5.5 | 2 | |
| Olfactory VAS Score (Mean ± SD) | 6.4 ± 3.7 | 0.3 ± 0.9 | |
CRSwNP, chronic sinusitis with nasal polyps; CRS chronic rhinosinusitis; SD, standard deviation; SNOT-22, Sino-nasal Outcome Test 22. * This encompasses traditional cigarettes, traditional shisha, and electronic shisha. ** Grading based on the Lidholt Polyp Grading Score System.